Point-of-Care EFIRM-based Liquid Biopsy for Actionable EGFR Mutations in NSCLCTuesday, 15 March 2016 at 09:30 Add to Calendar ▼2016-03-15 09:30:002016-03-15 10:30:00Europe/LondonPoint-of-Care EFIRM-based Liquid Biopsy for Actionable EGFR Mutations in NSCLCPoint of Care Diagnostics 2016 in Madrid, SpainMadrid, SpainSELECTBIOenquiries@selectbiosciences.com EFIRM Liquid Biopsy (eLB) permits near perfect detection of circulating tumor DNA (ctDNA) as compared with tissue genotyping, using a drop of bodily fluid, direct detection, without processing with results available in 10 minutes, at the point-of-care. |